News

In a study performed to evaluate and compare preserved versus unpreserved fluoroquinolone antibiotics, cell culture assays demonstrated some degree of toxicity and elevated induction of apoptosis in each of three commercially available topical ocular fluoroquinolone antibiotics.

Data from 1 year of follow-up in a 2-year study demonstrate a favorable clinical performance of a microincisional IOL designed for implantation through a 1.8 mm incision.

After years of wrangling in court with two former regional manufacturer's representatives, officials at STAAR Surgical Co. hope a $4 million settlement will allow it to move forward with new products and solidify its financial status.

The American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery are among 25 groups urging Congress to solve the Medicare physician payment problem.

With the FDA clearance of a new monofocal pseudophakic posterior chamber IOL comes the availability of a novel implant designed with a host of features that result in outstanding outcomes and that make the lens a premier option for most cataract surgery patients.

The first femtosecond-only method of laser vision correction is now able to be performed outside the United States after several years of clinical research and development, according to the manufacturer of the laser with which it is performed (VisuMax, Carl Zeiss Meditec).

A thermo-biomechanical system (Vedera, Avedro) for performing a proprietary procedure (Keraflex) to flatten the cornea in the treatment of myopia and keratoconus has received the European Union (EU) CE mark.